- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Aclarion, Inc.: Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts | 95 | GlobeNewswire (Europe) | Nociscan YOY scan volume increased 132% from Q2 2024 to Q2 2025 fueled by new physician adoption and insurance company coverage in the UK Company has achieved two consecutive quarters of scan volume... ► Artikel lesen | |
| 21.07. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.07. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| ACLARION Aktie jetzt für 0€ handeln | |||||
| 07.07. | Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders | 1 | GlobeNewswire (USA) | ||
| 25.06. | Aclarion Enrolls First Patient In CLARITY Trial Evaluating Nociscan In Spine Surgery | - | RTTNews | ||
| 25.06. | Aclarion, Inc.: First Patient Enrolled in Aclarion's Groundbreaking CLARITY Trial | 3 | GlobeNewswire (USA) | ||
| 24.06. | Aclarion, Inc.: Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum | 1 | GlobeNewswire (USA) | ||
| 20.06. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.06. | Aclarion, Inc.: Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site | 1 | GlobeNewswire (USA) | ||
| 30.05. | Aclarion stock price target cut to $20 at Ascendiant Capital | 2 | Investing.com | ||
| 30.05. | Kursziel für Aclarion-Aktie von Ascendiant Capital auf 20 US-Dollar gesenkt | 1 | Investing.com Deutsch | ||
| 26.05. | XFRA NEW INSTRUMENTS AVAILABLE ON 26.05.2025 | 488 | Xetra Newsboard | The following instruments on XETRA do have their first trading 26.05.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 26.05.2025
Aktien
1 MXCFFM010000 Banco Invex S.A.
2... ► Artikel lesen | |
| 20.05. | Aclarion, Inc.: Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site | 9 | GlobeNewswire (USA) | ||
| 15.05. | Aclarion, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 12.05. | Aclarion, Inc.: Aclarion Announces Texas Back Institute as New CLARITY Trial Site | 1 | GlobeNewswire (USA) | ||
| 05.05. | Aclarion, Inc.: Aclarion Welcomes Advocate Health as CLARITY Trial Site | 2 | GlobeNewswire (USA) | ||
| 29.04. | Aclarion, Inc.: Aclarion Announces Commercial Agreement with Spine Institute of Louisiana | 4 | GlobeNewswire (USA) | ||
| 23.04. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.04. | Aclarion, Inc.: Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025 | 2 | GlobeNewswire (USA) | ||
| 21.04. | Aclarion, Inc.: Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis | 2 | GlobeNewswire (USA) |
1 2 3 Weiter >>
44 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 404,40 | +0,16 % | Intuitive Surgical Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| UNITEDHEALTH | 219,95 | +2,04 % | UnitedHealth: Nächster Rückschlag | Viele Jahre galt die Aktie von UnitedHealth als Dauerläufer. Als Fels in der Brandung. Doch in den zurückliegenden Monaten sorgten zahlreiche negative Neuigkeiten dafür, dass der Dow-Jones-Wert binnen... ► Artikel lesen | |
| THERMO FISHER | 402,40 | +1,65 % | Plattform-Strategien krempeln Biotech-Markt um: BioNxt, Thermo Fisher Scientific, Evotec | Bei Biotech gilt längst nicht mehr das Prinzip alles oder nichts. Statt nur ein Produkt im Angebot zu haben, setzt sich bei der Entwicklung der Wirkstoffe von morgen die Plattform-Ökonomie durch. Was... ► Artikel lesen | |
| ROKU | 72,29 | +1,12 % | Roku startet neuen Dienst für 2,99 US-Dollar | ||
| SERNOVA BIOTHERAPEUTICS | 0,111 | -9,76 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,680 | +0,44 % | RedChip Companies, Inc.: Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | ORLANDO, FL / ACCESS Newswire / August 1, 2025 / RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and Atossa Therapeutics, Inc. (Nasdaq:ATOS) on the RedChip... ► Artikel lesen | |
| PING AN HEALTHCARE | 1,372 | +0,07 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand | HONG KONG and SHANGHAI, June 11, 2025 /PRNewswire/ -- The Ping An Good Doctor Brand Revamp & Ping An Healthcare Services Brand Launch Conference was held in Shanghai. Ping An Healthcare and... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Windtree Therapeutics: Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel | Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Contract inked with outside U.S manufacturer to cut PHEXXI manufacturing costs by over 50% by end of... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,011 | -21,92 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| CENTENE | 22,260 | +1,25 % | Sarah London, youngest CEO in Fortune 500 with US$20.6mn salary: Sarah London leads Centene, becoming youngest ... | ||
| CO-DIAGNOSTICS | 0,220 | +0,92 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| QUIDELORTHO | 21,800 | +5,83 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2025 Financial Results | ? Labs revenue grew 4% as reported and 5% in constant currency ?? Adjusted EBITDA margin improved by 330 basis points; Achieved $100 million annualized cost savings... ► Artikel lesen | |
| CYTOSORBENTS | 0,820 | -4,09 % | Cytosorbents Corp: CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., Aug. 7, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| VERU | - | - | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA8959792018 Trilogy AI Corp. 08.08.2025 CA88909Q1090 Tokenwell Platforms Inc. 11.08.2025 Tausch 1:1US92536C1036 Veru... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen |
Das Unternehmen ACLARION INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 6,080 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACLARION INC finden Sie auf Wallstreet Online.